National Taiwan University Hospital
Taipei, 100, Taiwan
Location status: Recruiting
NCT Number: NCT07710118
This is a study to compare the treatment effect of different doses of ceftriaxone for gonorrhea.
Interested in participating?
Request Info18 year and older
Male
Interventional
Phase 3
Taipei, 100, Taiwan
Location status: Recruiting
This is a noninferiority randomized controlled trial to compare the treatment effect of 500-mg to 1000-mg of ceftriaxone for uncomplicated gonorrhea infection in men.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
single-dose ceftriaxone 500-mg intramuscular injection, dissolved in 2 mL of 1% lidocaine hydrochloride solution
single-dose ceftriaxone 1000-mg intramuscular injection, dissolved in 3.5 mL of 1% lidocaine hydrochloride solution
Time frame: From enrollment to 14 days after treatment
The proportion of participants with successful treatment of UGI, defined as a NAAT-negative and, if applicable, a culture-negative result of the primary anatomic sites of infection 7-14 days after treatment; a culture-negative result is required only if N. gonorrhoeae culture was positive at the screening visit.
Time frame: From enrollment to 14 days after treatment
Symptom duration, including dysuria, genital discharge, sore throat, anorectal pain, rectal bleeding, and rectal discharge, in the subgroup of patients who have baseline symptoms attributable to UGIs.
Time frame: From enrollment to 14 days after treatment
Treatment-related adverse events until 14 days after treatment.
Time frame: From enrollment to 14 days after treatment
MIC of ceftriaxone of isolates at screening and test-of-cure (TOC) visits.
Time frame: From enrollment to 14 days after treatment
NG-MAST at screening and TOC visits.
Time frame: From enrollment to 14 days after treatment
Gene mutations associated with drug resistance for extended-spectrum cephalosporins at screening and TOC visits.
Contact information is provided by the study sponsor or research team.
National Taiwan University Hospital
Other
500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection: A Noninferiority Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07569900
Gonorrhea Infection
Johannesburg, Gauteng, South Africa
View Trial DetailsNCT06919614
Bacterial Infections, Bacterial Infections and Mycoses
Gaborone, Botswana
View Trial DetailsNCT06738407
Bacterial Infections, Bacterial Infections and Mycoses
Los Angeles, California, United States
View Trial DetailsNCT06844045
Bacterial Infections, Bacterial Infections and Mycoses
Philadelphia, Pennsylvania, United States
View Trial Details